VivoSeq
Other

Heavy Menstrual Bleeding

0

Pipeline Programs↗

4

Active Trials↗

4

Companies Involved↗

Heavy Menstrual Bleeding is an early-stage landscape with 0 programs across 4 companies. The most active players are Ferring, Bayer, Uteron Pharma S.A..

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Ferring logo

Ferring

0 programs

PreclinicalBayer logo

Bayer

0 programs

PreclinicalU

Uteron Pharma S.A.

0 programs

PreclinicalC

Channel Medsystems

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

18

clinical trials

Completed9 · 50%
Unknown status4 · 22%
Recruiting3 · 17%
Not yet recruiting1 · 6%
Withdrawn1 · 6%

Clinical Trials

Trial Activity

18 trials

A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD
Recruiting·UUnity Health Toronto·Phase 3·NCT06205095·20 enrolled
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Recruiting·OOregon Health and Science University·N/A·NCT05916469·300 enrolled
A Prospective, Observational, Multi-center Study to Gather Real World Use Data on the Effectiveness, Safety, and Site-of-service of the Cerene Device
Recruiting·—·N/A·NCT05922657·300 enrolled
Efficacy of Calcium Dobesilate Versus Tranexamic Acid for Treating Heavy Menstrual Bleeding
Not yet recruiting·UUniversity of Health Sciences Lahore·N/A·NCT06763094·100 enrolled
A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding
Completed·Ferring logoFerring·Phase 3·NCT01280981·288 enrolled
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Completed·Bayer logoBayer·Phase 3·NCT01638923·339 enrolled
Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding
Completed·UUteron Pharma S.A.·Phase 3·NCT01695902·280 enrolled
Tranexamic Acid in Adolescents With Heavy Menstrual Bleeding
Completed·NNationwide Children's Hospital·Phase 4·NCT01846507·32 enrolled
Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants
Completed·—·N/A·NCT04477837·84 enrolled
Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding
Completed·Bayer logoBayer·N/A·NCT00874653·78 enrolled
RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding
Completed·IIndiana University·Phase 2/3·NCT02829957·19 enrolled
Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding
Completed·Ferring logoFerring·Phase 4·NCT01190150·20 enrolled
Use of Recombinant Factor VII as a Prophylactic Therapy for Adolescent Females With Heavy Menstrual Bleeding
Completed·MMinia University Hospital·N/A·NCT06258980·3 enrolled
Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding
Withdrawn·UUniversity of Saskatchewan·Phase 1·NCT03027973
Estradiol vs Lysteda in Treatment of Heavy Menstrual Bleeding
Unknown status·KKay I Waud MD PhD·N/A·NCT01659008·100 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)